Effect of Lactate Export Inhibition on Anaplastic Thyroid Cancer Growth and Metabolism

被引:10
|
作者
Zhao, Bixiao [1 ]
Aggarwal, Abha [1 ]
Im, Soo-Yeon [2 ]
Viswanathan, Keya [1 ]
Landa, Inigo [2 ]
Nehs, Matthew A. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Surg, Boston, MA USA
[2] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA USA
关键词
HIF-1; DIMERIZATION; ANTITUMOR-ACTIVITY; ACRIFLAVINE; CELLS;
D O I
10.1097/XCS.0000000000000226
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Anaplastic thyroid cancer (ATC) is an aggressive malignancy without effective treatments. ATC cells demonstrate upregulated glycolysis (Warburg effect), generating lactate that is subsequently exported by monocarboxylate transporter 4 (MCT4). This study aims to determine whether MCT4 inhibition can suppress ATC growth. STUDY DESIGN: ATC cell lines 8505C, JL30, and TCO1 were grown in low (3 mmol/L; LG) or high (25 mmol/L; HG) glucose medium containing the lactate shuttle inhibitors acriflavine (10-25 mu mol/L; ACF), syrosingopine (100 mu mol/L; SYR), or AZD3965 (20 mu mol/L; AZD). Lactate level and cell proliferation were measured with standard assays. Seahorse analysis was performed to determine glycolytic response. RESULTS: Compared with HG, addition of ACF to LG decreased lactate secretion for both 8505C (p < 10(-5)) and JL30 (p < 10(-4)) cells, whereas proliferation was also reduced (p < 10(-4) and 10(-5), respectively). During Seahorse analysis, addition of oligomycin increased acidification by 84 mpH/min in HG vs 10 mpH/min in LG containing ACF (p < 10(-5)). Treatment with LG and SYR drastically diminished 8505C and TCO1 growth vs HG (p < 0.01 for both). LG and AZD treatment also led to reduced proliferation in tested cell lines (p <= 0.01 for all) that was further decreased by addition of ACF (p < 10(-4) vs HG, p <= 0.01 vs LG and AZD). CONCLUSION: Inhibition of lactate shuttles significantly reduced proliferation and glycolytic capacity of ATC cells in a low-glucose environment. Targeting suppression of glycolytic and lactate processing pathways may represent an effective treatment strategy for ATC. (C) 2022 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:1044 / 1050
页数:7
相关论文
共 50 条
  • [21] Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO)
    Yin, F
    Giuliano, AE
    Van Herle, AJ
    ANTICANCER RESEARCH, 1999, 19 (5B) : 4297 - 4303
  • [22] Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer
    Kimura, Takahito
    Doolittle, Woo Kyung Lee
    Kruhlak, Michael
    Zhao, Li
    Hwang, Eunmi
    Zhu, Xuguang
    Tang, Binwu
    Wolcott, Karen M.
    Cheng, Sheue-yann
    THYROID, 2024, 34 (04) : 484 - 495
  • [23] Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism
    Updegraff, Barrett L.
    Zhou, Xiaorong
    Guo, Yabin
    Padanad, Mahesh S.
    Chen, Pei-Hsuan
    Yang, Chendong
    Sudderth, Jessica
    Rodriguez-Tirado, Carla
    Girard, Luc
    Minna, John D.
    Mishra, Prashant
    DeBerardinis, Ralph J.
    O'Donnell, Kathryn A.
    CELL REPORTS, 2018, 25 (08): : 2223 - +
  • [24] Anaplastic thyroid cancer and hyperthyroidism
    Vijay Kumar
    Bruno Blanchon
    Xin Gu
    Marjorie Fowler
    David Scarborough
    Cherie Ann Nathan
    Subhashini Yaturu
    Endocrine Pathology, 2005, 16 : 245 - 250
  • [25] Anaplastic thyroid cancer: An update
    Rao, Sarika N.
    Smallridge, Robert C.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)
  • [26] Management of anaplastic thyroid cancer
    Keutgen, Xavier M.
    Sadowski, Samira M.
    Kebebew, Electron
    GLAND SURGERY, 2015, 4 (01) : 44 - 51
  • [27] Immunotherapy in anaplastic thyroid cancer
    Ma, Maoguang
    Lin, Bo
    Wang, Mingdian
    Liang, Xiaoli
    Su, Lei
    Okose, Okenwa
    Lv, Weiming
    Li, Jie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (03): : 974 - 988
  • [28] Lenvatinib for Anaplastic Thyroid Cancer
    Tahara, Makoto
    Kiyota, Naomi
    Yamazaki, Tomoko
    Chayahara, Naoko
    Nakano, Kenji
    Inagaki, Lina
    Toda, Kazuhisa
    Enokida, Tomohiro
    Minami, Hironobu
    Imamura, Yoshinori
    Sasaki, Tatsuya
    Suzuki, Takuya
    Fujino, Katsuki
    Dutcus, Corina E.
    Takahashi, Shunji
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [29] Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect
    Tseng, Yu-Ting
    Chang, Tien-Chun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (09) : 897 - 898
  • [30] Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
    Su, Xi
    Liu, Jiaxin
    Zhang, Haihong
    Gu, Qingqing
    Zhou, Xinrui
    Ji, Meiju
    Yao, Demao
    ONCOTARGETS AND THERAPY, 2020, 13 : 11183 - 11192